150 related articles for article (PubMed ID: 32437964)
21. High minichromosome maintenance protein 7 proliferation indices: a powerful predictor of progression in pancreatic neuroendocrine neoplasms without distant metastasis at the time of surgery.
Ban X; Yan J; Yu S; Lu Z; Chang X; Jia C; Gao C; Shao H; Wu Y; Mao X; Zhang Y; Li Y; Chen J
Hum Pathol; 2019 Mar; 85():101-111. PubMed ID: 30447299
[TBL] [Abstract][Full Text] [Related]
22. Proinsulin-secreting neuroendocrine tumor of the pancreas.
Piovesan A; Pia A; Visconti G; Terzolo M; Leone A; Magro G; Cesario F; Borretta G
J Endocrinol Invest; 2003 Aug; 26(8):758-61. PubMed ID: 14669832
[TBL] [Abstract][Full Text] [Related]
23. Degradation during storage of high molecular weight immunoreactive insulin (HWIRI) and proinsulin (PLC) in extracts of Benign insulinomas and adjacent pancreatic tissue.
Villaume C; Beck B; Pointel JP; Drouin P; Debry G
Horm Metab Res; 1981 Sep; 13(9):528-9. PubMed ID: 6271661
[No Abstract] [Full Text] [Related]
24. Inhibitory effect of islet amyloid polypeptide of glucose-induced proinsulin biosynthesis in rat insulinoma cells.
Chuang LM; Wu HP; Jou TS; Tai TY; Lin BJ
Pancreas; 1992; 7(4):472-6. PubMed ID: 1641390
[TBL] [Abstract][Full Text] [Related]
25. Human insulinoma hybrids produce proinsulin-like material.
Boyd AE; Riser ME; Bolton WE; Siciliano MJ
Diabetes; 1982 Dec; 31(12):1035-40. PubMed ID: 6293898
[TBL] [Abstract][Full Text] [Related]
26. An Insight on Functioning Pancreatic Neuroendocrine Neoplasms.
Bevere M; Gkountakos A; Martelli FM; Scarpa A; Luchini C; Simbolo M
Biomedicines; 2023 Jan; 11(2):. PubMed ID: 36830839
[TBL] [Abstract][Full Text] [Related]
27. Application of multiomics sequencing and advances in the molecular mechanisms of pancreatic neuroendocrine neoplasms.
Jiang R; Hong X; Zhao Y; Wu W
Cancer Lett; 2021 Feb; 499():39-48. PubMed ID: 33246093
[TBL] [Abstract][Full Text] [Related]
28. Serine protease inhibitor 8 is a novel immunohistochemical marker for neuroendocrine tumors of the pancreas.
de Koning PJ; Bovenschen N; Broekhuizen R; Lips CJ; Kummer JA
Pancreas; 2009 May; 38(4):461-7. PubMed ID: 19188865
[TBL] [Abstract][Full Text] [Related]
29. Hyperproinsulinemia and amyloid in NIDDM. Clues to etiology of islet beta-cell dysfunction?
Porte D; Kahn SE
Diabetes; 1989 Nov; 38(11):1333-6. PubMed ID: 2695369
[TBL] [Abstract][Full Text] [Related]
30. The focal form of persistent hyperinsulinemic hypoglycemia of infancy: morphological and molecular studies show structural and functional differences with insulinoma.
Sempoux C; Guiot Y; Dahan K; Moulin P; Stevens M; Lambot V; de Lonlay P; Fournet JC; Junien C; Jaubert F; Nihoul-Fekete C; Saudubray JM; Rahier J
Diabetes; 2003 Mar; 52(3):784-94. PubMed ID: 12606521
[TBL] [Abstract][Full Text] [Related]
31. Glucagon-like peptide-1 improves insulin and proinsulin binding on RINm5F cells and human monocytes.
Ebinger M; Jehle DR; Fussgaenger RD; Fehmann HC; Jehle PM
Am J Physiol Endocrinol Metab; 2000 Jul; 279(1):E88-94. PubMed ID: 10893327
[TBL] [Abstract][Full Text] [Related]
32. The number of positive nodes accurately predicts recurrence after pancreaticoduodenectomy for nonfunctioning neuroendocrine neoplasms.
Partelli S; Javed AA; Andreasi V; He J; Muffatti F; Weiss MJ; Sessa F; La Rosa S; Doglioni C; Zamboni G; Wolfgang CL; Falconi M
Eur J Surg Oncol; 2018 Jun; 44(6):778-783. PubMed ID: 29610023
[TBL] [Abstract][Full Text] [Related]
33. Contrasting patterns of insulin biosynthesis, compartmental storage, and secretion. Rat tumor versus islet cells.
Gold G; Gishizky ML; Chick WL; Grodsky GM
Diabetes; 1984 Jun; 33(6):556-61. PubMed ID: 6202578
[TBL] [Abstract][Full Text] [Related]
34. Human insulinoma tissue: in vitro studies of proinsulin/insulin biosynthesis and release.
Track NS; Creutzfeldt C; Creutzfeldt W
Horm Metab Res; 1976; Suppl 6():19-25. PubMed ID: 179925
[TBL] [Abstract][Full Text] [Related]
35. Altered glucose regulation of insulin biosynthesis in insulinoma cells: mouse beta TC3 cells secrete insulin-related peptides predominantly via a constitutive pathway.
Nagamatsu S; Steiner DF
Endocrinology; 1992 Feb; 130(2):748-54. PubMed ID: 1733723
[TBL] [Abstract][Full Text] [Related]
36. Galanin inhibits proinsulin gene expression stimulated by the insulinotropic hormone glucagon-like peptide-I(7-37) in mouse insulinoma beta TC-1 cells.
Fehmann HC; Habener JF
Endocrinology; 1992 May; 130(5):2890-6. PubMed ID: 1374016
[TBL] [Abstract][Full Text] [Related]
37. Are biochemical markers of neuroendocrine tumors coreleased with insulin following local calcium stimulation in patients with insulinomas?
Wiesli P; Uthoff H; Perren A; Pfammatter T; Zwimpfer C; Seiler H; Kindhauser R; Spinas GA; Schmid C
Pancreas; 2011 Oct; 40(7):995-9. PubMed ID: 21705951
[TBL] [Abstract][Full Text] [Related]
38. Molecular profile of pancreatic neuroendocrine neoplasms (PanNENs): Opportunities for personalized therapies.
Arakelyan J; Zohrabyan D; Philip PA
Cancer; 2021 Feb; 127(3):345-353. PubMed ID: 33270905
[TBL] [Abstract][Full Text] [Related]
39. [Conversion of proinsulin into insulin in insulin producing tumors in man].
Pigareva MI
Probl Endokrinol (Mosk); 1976; 22(3):15-8. PubMed ID: 180518
[TBL] [Abstract][Full Text] [Related]
40. Neuropilin-2 is a novel marker expressed in pancreatic islet cells and endocrine pancreatic tumours.
Cohen T; Herzog Y; Brodzky A; Greenson JK; Eldar S; Gluzman-Poltorak Z; Neufeld G; Resnick MB
J Pathol; 2002 Sep; 198(1):77-82. PubMed ID: 12210066
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
